We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Three new specialised treatments are now to be made available on the NHS for patients in England after being initially rejected for funding back in December, NHS England has announced.
Apollo Therapeutics (‘Apollo’), the collaborative venture between three world-leading UK universities and three global pharmaceutical companies, has invested in and launched the first of its drug discovery programmes in collaboration with academics at eac
The National Health and Medical Research Council funding of A$125.3 million ($95.9 million) includes almost A$39 million to fight multiple types of cancer facing children and adults
The Victorian Government in Australia is planning to introduce a new pollen monitoring network as part of a package to combat thunderstorm asthma. The A$1m ($0.75m) package also includes new funding to understand and predict the phenomenon of asthma.